Author

Sarah Camille Glover

Tulane UniversityORCID 0000-0002-9899-0473Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alex K. ShalekiD· 2 shared Bruce Harold HorwitziD· 2 shared Jaclyn M. L. WalshiD· 2 shared Jonathan J. LyonsiD· 2 shared José Ordovás-MontañésiD· 2 shared Kyle KimleriD· 2 shared Ying TangiD· 2 shared Abdul Karim SesayiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alex K. ShalekORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintApr 24, 2026

Unique nasal cell states induced by common pediatric respiratory viruses

Jaclyn M. Long, Lillian J. Juttukonda, Ying Tang…·Bruce Harold Horwitz

This study maps virus-specific nasal cell states in children using single-cell RNA sequencing and links them to disease severity and asthma risk.

DOI 10.64898/2026.04.20.719671

𝕏 PostBluesky

ImmunologyNature ImmunologyPeer-reviewedJan 20, 2025

Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2

Jaclyn M. L. Walsh, Vincent N. Miao, Anna H. Owings…·José Ordovás-Montañés

This study examines how SARS-CoV-2 variants and vaccination affect nasal immunity across three waves, identifying changes in cellular states and immune responses.

16 citationstop 1%

𝕏 PostBluesky

Genetic & Genomic MedicineBlood AdvancesPeer-reviewedSep 28, 2022

Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms

Jack F. Chovanec, Ilker Tunc, Jason Hughes…·Jonathan J. Lyons

This study determines individualized tryptase reference ranges by modeling BST levels based on TPSAB1 copy number, showing that elevated levels can indicate clonal myeloid neoplasms or be normal in HT carriers.

62 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky